MTLHY

Opening and Strategic Context

• FY 2025 results were highly challenging, with core operating income down 2% and net income down 74%, driven by large non-recurring charges from decisive structural reforms executed to clear the deck for future growth. Completed key actions: withdrawal from the coke and carbon materials business, ethylene restructuring in Western Japan, dissolution of overseas MMA joint ventures, a voluntary retirement program, and recognition of nearly all major impairment losses tied to these reforms within FY 2025.
• Management took accountability for the 30 billion yen impairment on the U.K. Soarnol plant investment, which caused FY 2025 results to miss prior forecasts. The CEO and Soarnol business head implemented a 20% voluntary compensation cut for 6 months, and management will institute stricter investment oversight for all future projects. No similar impairment risks have been identified in other ongoing projects.
• Reached and exceeded the medium-term management plan's 400 billion yen divestment target over the past two years, completing 490 billion yen in divestitures to refocus the portfolio on growth businesses and strengthen the balance sheet. Net debt-to-equity improved to 0.83 from 1.06 year-over-year, driven by proceeds from asset sales including Mitsubishi Tanabe Pharma.

Disciplined Management Delivery

• The three principles of disciplined management (pricing discipline, investment discipline, asset optimization) delivered 58 billion yen in impact in FY 2025: 29 billion yen from pricing initiatives (reducing loss-making sales, expanding cost-linked pricing) and 29 billion yen from asset optimization (cost cuts from capacity reductions and exit from unprofitable operations).
• Starting from FY 2027 (ending March 2028), the company will reorganize its reporting segments to improve oversight: the legacy Specialty Materials segment will be split into five focused segments (Films and Performance Materials, Composites and Shapes, Information Electronics, Polymer Compounds, Water and Infrastructure), while MMA & Derivatives remains unchanged and Basic Materials consolidates the legacy Basic Materials and Polymers businesses.

Growth Business Update

• Large-scale growth investments are coming online: a new polyester film line in Germany has commenced operations, carbon fiber composite production for robotaxis is ramping up, semiconductor-related businesses (synthetic quartz, precision cleaning) are seeing strong demand, and new aerospace and drone projects are progressing. Capacity expansion for carbon fiber composites in Italy and Soarnol barrier packaging in the U.K. continued through FY 2025.

• For FY 2026 (ending March 2027), consolidated core operating income is guided to 305 billion yen, an 80 billion yen increase year-on-year. Net income attributable to owners of the parent is guided to 127 billion yen, up 115.2 billion yen year-on-year, as large non-recurring FY 2025 losses do not repeat. Sales revenue is forecast at 3.8 trillion yen, up 96 billion yen from FY 2025. Guidance assumes an exchange rate of 150 yen per U.S. dollar and naphtha price of 63,000 yen per ton.
• The 18 billion yen downside core operating income impact is already estimated if current Middle East tensions persist through September 2026; this impact is not included in the base 305 billion yen guidance. Over half of this potential impact (10 billion yen) would fall on MMA & Derivatives, 6 billion yen on Specialty Materials, and 2 billion yen on Basic Materials.
• By segment: Specialty Materials is expected to grow significantly driven by higher sales of growth products (MLCC polyester film, Soarnol barrier packaging, semiconductor-related goods, robotaxis composites) and the absence of FY 2025's Soarnol impairment. MMA & Derivatives is expected to return to profitability on gradual market recovery and higher volumes. Basic Materials is expected to narrow its loss, as the FY 2025 ethylene oxide/glycol impairment does not repeat. Industrial Gases is expected to deliver steady profit growth from pricing and productivity.
• Disciplined management initiatives are expected to deliver 48 billion yen in benefits in FY 2026, including continued pricing increases in Specialty Materials, profit contributions from full-scale robotaxi composite shipments, and fixed cost reductions from the FY 2025 voluntary retirement program.
• The FY 2025 year-end dividend is maintained at 16 yen per share. For FY 2026, the annual dividend is guided to 32 yen per share (16 yen interim, 16 yen year-end), unchanged from the FY 2025 full-year payout.

For full-year FY 2025, consolidated sales revenue was 3,704 billion yen, down 343.6 billion yen year-on-year, and core operating income was 225 billion yen, down 3.8 billion yen (-2%) year-on-year. Net income attributable to owners of the parent was 11.8 billion yen, down 33.2 billion yen (-74%) year-on-year, heavily impacted by 194.9 billion yen in non-recurring negative special items from structural reforms.

1. Chemicals Segment (overall): Sales revenue decreased 11% year-on-year, core operating income came in at 24.3 billion yen, a 43% decline (down 18.4 billion yen) year-on-year. This decline was driven primarily by weak MMA monomer market conditions and the 30.3 billion yen Soarnol U.K. impairment loss.

• Specialty Materials: Core operating income increased 8.4 billion yen year-on-year, before a 29 billion yen negative adjustment for the Soarnol U.K. impairment and inflation costs. Volume grew 15.5 billion yen (led by semiconductor precision cleaning, robotaxi carbon fiber parts, and semiconductor manufacturing engineering plastics), pricing improved 8.1 billion yen, and cost cuts added 13.8 billion yen. In Q4 FY 2025, the segment recorded a 12.9 billion yen loss, down 25 billion yen from Q3 profit due to the Soarnol impairment.
• MMA and Derivatives: Core operating income decreased 37.2 billion yen year-on-year, as the MMA monomer market saw sharp price declines that widened spread compression. The segment recorded a 3.1 billion yen loss in Q4 FY 2025, largely flat quarter-over-quarter.
• Basic Materials and Polymers: Narrowed its core operating loss by 10.4 billion yen year-on-year. Pricing improved 11.4 billion yen (from polyolefin price lags during naphtha price declines and reduced loss-making carbon business transactions), and cost cuts added 7.1 billion yen, offset by 9 billion yen in negative items from ethylene oxide/glycol impairment and poor inventory valuation. The segment recorded a 1.3 billion yen loss in Q4 FY 2025, with wider losses from the ethylene impairment.

1. Industrial Gases Segment: Revenue increased 4% year-on-year, core operating income increased 14.6 billion yen (+8%) year-on-year to 200.7 billion yen. Q4 core operating income rose to 56.3 billion yen from 51.4 billion yen in Q3, driven by pricing management and productivity improvements, despite higher U.S. electricity costs and soft volumes in Europe/North America.

• Geopolitical risk from ongoing Middle East tensions is the primary near-term uncertainty. If tensions persist through September 2026, the company estimates an 18 billion yen downside impact to core operating income, driven primarily by supply chain disruptions that reduce customer demand for the company's products rather than inability to pass through higher raw material costs. Most of the impact would fall on MMA & Derivatives, with smaller impacts on Specialty Materials and Basic Materials.
• While the company has proactively diversified procurement routes and adjusted logistics to mitigate raw material supply risks, persistent tensions could lead to unexpected supply chain bottlenecks or reduced production that negatively impact results. There is also continued uncertainty around naphtha price volatility, which creates quarterly profit swings that are difficult to forecast accurately.
• The MMA market remains particularly challenging and volatile, with mixed pricing signals between regional markets that make future performance difficult to forecast accurately.
• While management has strengthened investment oversight after the Soarnol U.K. impairment, future large-scale growth projects could still face delays, cost overruns, or market changes that result in unanticipated losses.
• Persistent weak demand in Europe and North America for EV-related materials and general industrial products could pressure volume and margins across multiple segments.

Q: Can you elaborate on the 18 billion yen projected downside impact from Middle East tensions, including raw material procurement and inventory valuation impacts? / A: The 18 billion yen estimate assumes tensions persist through September. While higher naphtha procurement costs can generally be passed through to customers, and there is no expected risk of production halts from raw material shortages, the main downside comes from supply chain disruptions that reduce customer order volumes. Over half of the 18 billion yen impact is allocated to MMA & Derivatives, driven by trade logistics disruptions for Middle East-sourced materials. Quarterly naphtha price volatility typically creates offsetting impacts across periods, with minimal net long-term effect.

Q: What is driving the large expected profit increase for Specialty Materials in FY 2026, particularly for Composites and Shapes tied to robotaxis? / A: The largest single factor is the absence of the 30 billion yen Soarnol impairment recorded in FY 2025. For Composites and Shapes, robotaxis shipments are expected to triple to quadruple year-on-year, and prior upfront investments mean the business will start generating profits as volumes rise. Production consolidation in Italy has also eliminated prior unprofitable output. Additional growth will come from newly commissioned MLCC polyester film capacity in Germany that is now shipping after customer certification, steady Soarnol volume growth, and rising semiconductor-related demand for synthetic quartz and other products. Contractual restrictions prevent disclosure of exact shipment volumes.

Q: What is the breakdown of the 35 billion yen in asset optimization benefits expected for FY 2026, and was the FY 2025 target miss entirely driven by impairment losses? / A: Excluding all impairment losses from FY 2025, core operating income for chemical businesses was very close to the original guidance range, confirming that underlying operational initiatives met expectations. For the FY 2026 asset optimization target of 35 billion yen, roughly 10 billion yen comes from fixed cost reductions from the FY 2025 Next-stage Support Program headcount reduction, more than 10 billion yen comes from cost savings from production site consolidation and variable cost reduction across businesses, and the remaining few billion yen comes from centralized procurement and logistics optimization.

Q: Why is the projected 10 billion yen Middle East impact on MMA negative even when current MMA market prices are rising alongside methanol/naphtha costs? / A: The 10 billion yen negative impact is almost entirely a volume effect, not a spread effect. The base forecast assumed normal exports of MMA-related products from Middle East producers; if tensions persist, Middle East production and exports will slow, leading to lower sales volumes for Mitsubishi Chemical due to indirect supply chain impacts. While current spot prices have risen to around $2,000/ton from the base assumption of ~$1,400/ton, actual pricing in China is weaker than spot indices suggest, making the overall outlook highly uncertain. The 10 billion yen estimate reflects a conservative volume outlook, not a negative margin assumption.